CRISTY BEDDINGFIELD: Open Payments
NPI 1245297779 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 65 payments from 16 companies in 2025. Trend: 2023 $1,501 · 2024 $1,539 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $389 |
| Amgen Inc. | 14 | $199 |
| PFIZER INC. | 5 | $99 |
| UCB, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Lilly USA, LLC | 3 | $54 |
| ABBVIE INC. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Abbott Laboratories | 2 | $30 |
| Lundbeck LLC | 1 | $26 |
Products named: Wegovy, Ozempic, REPATHA, ELIQUIS, Zilbrysq, EVENITY, LEQVIO, UBRELVY.
Industry payments across GA — which companies pay providers there.
